Limited trypsin digestion of type I cAMP-dependent protein kinase holoenzyme results in a proteolytic-resistant ∆(1-72) regulatory subunit core, indicating that interaction between the regulatory and catalytic subunits extends beyond the autoinhibitory site in the R subunit at the N-terminus. Sequence alignment of the two R subunit isoforms, RI and RII, reveals a significantly sequence diversity at this specific region. To determine whether this sequence diversity was functionally important for interaction with the catalytic subunit, specific mutations, R133A and D328A, are introduced into sites adjacent to the active site cleft in the catalytic subunit. While replacing Arg133 with Ala decreases binding affinity for RII, interaction between the catalytic subunit and RI is not affected. In contrast, mutant C(D328A) showed a decrease in affinity for binding RI while maintaining similar affinities for RII as compared with the wild type catalytic subunit. These results suggest that sequence immediately N-terminal to the consensus inhibition site in RI and RII interacts with different sites at the proximal region of the active site cleft in the catalytic subunit. These isoform-specific differences would dictate a significantly different domain organization in the type I and type II holoenzymes.
INTRODUCTION
The regulatory (R § ) subunits of cAMP-dependent protein kinase (PKA) are multifunctional proteins that control in a variety of ways the physiological functions of this ubiquitous protein kinase (1, 2) . While the R subunits have long been recognized as the primary receptor for cAMP and the major physiological inhibitor for the catalytic (C) subunit in eukaryotic cells, it is now apparent that these highly modular proteins play other important roles as well (3) . The R subunits of PKA have a well-defined domain structure that consists of a dimerization domain at the N-terminus followed by an autoinhibitor site and two-tandem cAMP binding domains. While the portion of the R subunit C-terminal to the inhibition site is responsible for high affinity binding of the C subunit and cAMP, the remaining Nterminus serves as an adaptor for binding to kinase anchoring proteins (3) and other adaptor proteins, such as the SH3-containing Grb2 (4) . This segment or region of the R-subunit is responsible for in vivo subcellular localization and targeting of PKA.
There are two general classes of PKA, designated as type I and type II, due exclusively to differences in the R subunits, RI and RII (5-7). Four different regulatory subunits, RIα (8) , RIβ (9), RIIα
Isozyme II was pooled and used for all experiments.
Wild type RIα was purified using DE52 anion exchange chromatography followed by FPLC gel filtration on Superdex 200 (Pharmacia) as described previously (35). H 6 -RIα was purified on nickel resin (Qiagen) and RIIβ was isolated by co-purification with H 6 -C using a protocol similar to that of Hemmer et al. (36) . Briefly, equal volumes of E. coli cultures that overexpressed RIIβ and H 6 -C were mixed and co-lysed in the presence of 5 mM MgATP. After batch binding the holoenzyme onto Ni 2+ -resin, the free RII was eluted with 5 mM cAMP. Pooled fractions from the cAMP elution were precipitated with ammonium sulfate, and further purified by FPLC gel filtration on a Superdex 200 column. To obtain cAMP-free R-subunits, RIα and RIIβ were dialyzed against 8 M urea to completely remove cAMP. The chemically denatured R subunits were then refolded by dialysis to remove the urea (37), and further purified by passing through a Superdex 200 gel filtration column. All proteins were at least 95% pure judged by SDS-polyacrylamide gel electrophoresis.
Holoenzyme formation: PKA holoenzymes were reconstituted from individually purified C and R subunits by mixing freshly isolated R and C subunits in a molar ration of 1:1.2 and dialyzed against buffer A (20 mM potassium phosphate, 100 mM KCl, 2mM DTT, 0.1 mM ATP, 1 mM MgCl 2 , and 5% glycerol, pH 6.5) extensively at 4 °C to remove excess cAMP. The dialyzed sample was assayed for PKA activity first in the absence of cAMP and then in the presence of 100 µM cAMP to confirm the formation sample buffer after incubating at room temperature for 10 or 30 min. The samples were boiled for 2 min and loaded onto a 12% SDS-PAGE for analysis of the digestion products.
Sequencing of cleavage products: After electrophoresis, proteins were transblotted onto a PVDF (0.2 µm, Bio -Rad ) membrane. The electroblotting was performed in 10 mM Caps, 10% methanol (pH 11) buffer at 200 mA constant current for 1 hr. After rinsing with water (3 times) and methanol, the membrane was stained with 0.1% Commassie R-250 in 1% acetic acid/40% methanol for 2 min. The membrane was destained in 50 % methanol and patted dry after rinsing with water. The protein bands of interest were excised from the membrane with a razor blade and subjected to N-terminal protein sequencing.
Protein kinase activity assay:
The enzymatic activity of the C subunit was measured spectrophotometrically with a coupled enzyme assay (38). In this assay, the formation of the ADP is coupled to the pyruvate kinase and lactate dehydrogenase reactions. The reaction rate is determined by following the decrease in absorbance at 340 nm. Reactions were pre-equilibrated at room temperature and initiated by adding the peptide substrate. The Michaelis-Menten parameters for ATP and Kemptide were determined by fixing one substrate at near saturating concentration while varying the concentration of the other substrate.
Inhibition of the catalytic subunit by R or PKI was assayed by mixing varying amount of inhibitor with 20 nM C-subunit and subsequently determining the decrease of phosphotransfer activity.
A radioisotopic method (39) was also used to measure the activity of the C-subunit at low concentration, typically around 100 pM. With this assay, the inhibition constants of R and PKI to the catalytic subunit can be accurately determined. and 500 nM were performed and sensorgrams were collected for each injection. The C subunit surface was regenerated by injection of 10 µl of 10 µM cAMP and 4 mM EDTA in running buffer following each injection of R subunit.
Kinetic constants of binding were obtained using the BIAcore pseudo-first-order rate equation:
Where k asso is the association rate, k diss is the dissociation rate, C is the concentration of injected analyte, and R is the response. The dissociation rate, k diss , was calculated by integrating the rate equation when C=0, yielding ln(R t1 /R tn )=k diss (t n -t 1 ). Plots of dR/dt vs. R t have a slope of k diss . Plotting k diss against C gives a slope that is equal to the k asso . Affinity constants were calculated from the equation and 91) was also involved in the holoenzyme formation.
Isoform specific differences in the P-11 to P-4 region of RI and RII subunits. The proteolysis results led us to focus on potential interactions between the first few residues (P-11 to P-4) that lie Nterminal to the consensus peptide of R subunits at the active site cleft of the C subunit. A close comparison of the structure of C:PKI(5-24) and the isoform specific differences between the RI and RII subunits (Figure1) suggested that there may be key differences in the way that the R subunits in the P-11 to P-4 region N-terminal to the consensus site complement the active site of the C-subunit. This led us to further probe the interactions between the C-subunit and R subunit isoforms by introducing two mutations (R133A and D328A) into the C-subunit around the active site cleft.
Characterization of catalytic mutants. Mutants C(R133A) and C(D328A) expressed in E. coli to levels that were similar to the wild type C and could be purified readily to homogeneity using the conventional or co-lysis purification procedures. The purified mutants, (isozyme II) phosphorylated at Ser338, Thr197, and Ser10, have atomic masses of 40597±5 and 40642±4, respectively, as determined by electron spray mass spectroscopy. These values are in good agreement with the calculated values of 40597 and 40638 as expected for the Arg to Ala and Asp to Ala mutations.
The steady-state kinetic properties of the mutants were determined and summarized in Table I . the ability of these mutant C subunits to be inhibited by RIα, RIIβ and PKI was tested using the spectrophotometric assay. When 20 nM of the wild type and mutant catalytic subunits were used in the assay, cAMP-free RIα titrated the C(R133A) and wild type C subunits stoichiometrically, indicating that the affinity of RIα for these C subunits is much lower than 20 nM. However, mutant C(D328A) required higher concentrations of RIα to be inhibited to the same extent as the wild-type C subunit. Quantitative analysis of the inhibition curve gave an apparent inhibition constant of 28 nM ( Figure 3A ) and a calculated intrinsic inhibition constant of 2.2 nM (Table II) . The opposite was observed when stripped RIIβ was used. RIIβ, while it inhibited the wild type C and C(D328A) readily, showed a decreased affinity toward C(R133A) ( Figure 3B ). The measured K i,app and K i of RIIβ to C(R133A) were 21 nM and 1.9 nM, repetively (Table II) . Interaction between PKI and mutant catalytic subunits were also measured.
As shown in Figure 3C , linear inhibition curves were obtained when the wild type and C(D328A) were titrated with PKI. In contrast, the inhibition constants of PKI to C(R133A) were 888 nM and 83 nM, for K i,app and K i , repectively. These results were in good agreement with the early observation (32).
The radioisotopic method was also used to study the tight interaction between catalytic subunits and R subunits and PKI so that the effects of mutations C(R133A) and C(D328A) on interaction with RIα, RIIβ and PKI could be quantitatively assessed and compared. Since it was possible to measure the PKA activity at very low concentration (pM) with the radioisotopic method, subnanomolar affinity could be easily measured. Inhibition of 100 pM of wild type and C(D328A) catalytic subunits by PKI was measured by 32 P-phosphorylation of Kemptide, and the result was summarized in Figure 4A . It was clear that unlike C(R133A), mutant C(D328A) interacted with PKI with high affinity similar to the wild type C-subunit. The inhibition constant, K i , for C(D328A) is 0.49 nM (Table II) .
The inhibition constants for RI to wild-type C and C(R133A) and for RII to wild-type C and C(D328A) were also determined ( Figure 4B and 4C) . These inhibition constants, summarized in Table II , established clearly that mutation of 133 reduced affinity of the C subunit for RII and PKI but not for RI.
In contrast, mutation of 328 affected interaction between C and RI but not RII and PKI.
R-C interaction measured by surface plasma resonance. As mentioned above, interaction between C(R133A) and RIα and between C(D328A) and RIIβ, was measured indirectly by the ability of these mutants be inhibited by the R-subunits. Surface plasmon resonance was used to further confirm these observations and to obtain a direct estimation of the binding affinities of these mutant C-subunits to binding of RIα and RIIβ was measured.
The association and dissociation constants for wild type, C(R133A) and C(D328A) C subunits obtained by SPR measurements were summarized in Table III 
DISCUSSION
Two major interaction sites between the R and C subunits were defined previously (36, 41, 42).
One is the autoinhibitory consensus site in the linker region of R that fills the active site cleft of the C subunit and competes for the substrate-binding site (41) . The other site, termed a peripheral recognition site, lies C-terminal to the inhibitory consensus site and complements the surface of C that is dominated by (P)Thr197 and the activation loop (36, 42, 43) . This peripheral recognition site is an essential docking surface for cAMP binding domain A in the holoenzyme complex. The exact boundaries of R/C interaction at the active site cleft, however, are not clear at present. Using limited trypsin digestion to map the core of the type I holoenzyme complex, the apparent protection of two tryptic cleavage sites, at residues 76 and 90, between residue 72 and the pseudo-substrate inhibition site in the R subunit clearly suggests that the N-terminal boundary of the RI subunit interaction site is between residues 72 and 76, indicating that this region that lies N-terminal to the inhibition site may also play an important role in R/C interaction.
Although all R subunit isoforms share extensive sequence similarity and contain two tandem cAMPbinding domains that are homologous to the cAMP-binding domain of the cAMP receptor protein (CRP) in E. coli (25) , RI and RII show distinct sequence differences that are conserved within each sub-family (44) . These sequence differences are most striking in the linker region that extends from the dimerization/docking domain through the consensus inhibitor site. In RII the consensus inhibitor site contains the sequence RRXS, an autophosphorylation site for C (26) , whereas the RI has the sequence RRXA that cannot be autophosphorylated but is important for high affinity binding of MgATP (28) .
However, the differences between RI and RII cannot be accounted for exclusively by the presence or absence of the autophosphorylation site. Given the proteolysis results, coupled with modeling based on the C:PKI crystal structure, we reasoned that the residues that immediately precede the consensus site arginines might be important for holoenzyme formation. This analysis led us to test two specific sites, R133 and D328, on the surface of the C subunit as potential isoform-specific interaction sites for the P-11
to P-4 regions of RI and RII.
R133 and D328, located on the N-terminal proximal side of the peptide-binding site in the catalytic subunit, define two potential binding sides that lie on opposite sites of the peptide-binding cleft.
R133 reaches out from the large lobe and is part of the hydrophobic binding pocket where the P-11 Phe in PKI docks, while D328, is part of the mobile acidic patch in the C terminal tail that is functionally a part of the small lobe ( Figure 5 ). D328 was identified as a putative recognition site for a basic residue at the P-4 position of peptide substrates when an oriented peptide library was screened to determine the optimal peptide substrate (45) . Substitution of R177 and K178 (the R133/R134 equivalents) of the yeast C-subunit with Ala caused a 4.2 fold decrease in binding affinity for the yeast R subunit, which is more closely related to the mammalian type II R subunit, without impairing the catalytic activity (43) . The equivalent mutations in murine C subunit (R133A/R134A) led to a defect in PKI interaction without significantly affecting the interaction with the RI subunit (32) . R133, together with Tyr235, Pro236, and Phe 239 form the hydrophobic P-11 binding pocket that is necessary for tight binding of PKI (32) . Based on these observations and on the isoform specific differences in RI and RII in the P-6 to P-4 region, mutations of R133A and D328A were introduced to dissect interaction between the catalytic subunit and specific regulatory subunit isoforms.
C(R133A) and C(D328A) exhibited similar kinetic parameters both for Kemptide and ATP as the wild-type C indicating interaction between the mutant C subunits and this substrate is not significantly perturbed by these mutations. On the other hand, a fivefold decrease in binding affinity between C(D328A) and RIα was observed while interaction of C(D328A) with RIIβ and PKI remained unchanged. Hence, it can be concluded that D328 is a RI-specific interaction site. This is consistent with the mutational study showing that equivalent mutation in yeast C subunit does not affect its interaction with the yeast R subunit, which is more closely related to the type II R subunits (43) . Based on sequence alignment of R subunits and PKI, only RI subunits contain a conserved Arg at the P-4 position. The likely reason for such selectivity is that a basic residue at P-4 position can interact favorably with Asp 328 (45) .
Manual substitution of the P-4 Gly of PKI with Arg in C:PKI crystal structure model confirms that Asp 328 is within hydrogen-bonding distance with the guanidine group of the P-4 Arg.
Mutation R133A significantly impairs the interaction of C with PKI. The measured inhibition constant, K i , for the mutant C was increased more than 300 fold, in a good agreement with an early study (32) . Interaction between C(R133A) and RIIβ was also affected, but to much less extent with a five-fold decrease in binding affinity, whereas C(R133A) mutant was identical to the wild type C-subunit in terms of forming holoenzyme with the RIα subunit. The interaction of R subunits with C at the N-terminal proximal side of the peptide-binding site is thus isoform specific. Furthermore, RII is more like PKI than RI in terms of interacting with C at the N-terminal proximal side of the peptide-binding site. This is in contrast to the consensus site peptide itself where PKI more closely resembles RI having (1) an Ala at the P site and (2) an ATP requirement for tight binding to C. These differences can be attributed to the diversity of the amino acid sequence immediately N-terminal to the auto-inhibition site in the RI and RII subunits. In this region, while RI and RII differ significantly, sequence similarity between RII and PKI is apparent. Both RII and PKI contain an Arg at the P-6 position and this Arg is important for PKI binding to C (46) . Although RII lacks the P-11 Phe, another important amino acid in PKI that is critical for catalytic subunit recognition, modeling of the C:PKI crystal structure by substituting the P-5 threonine with phenylalanine, a conserved amino acid residue in RII, suggests that the aromatic side chain of this P-5 phenylalanine can reach down to occupy the space that is filled by the P-11 Phe in PKI. Thus, the highly conserved P-5 Phe in RII can potentially function in a similar way as the P-11 Phe in PKI. Both side chains could fill the same hydrophobic pocket formed by Arg 133, Tyr 235, Pro 236 and Phe 239.
The P-6 Arg of RII would then fill the same position as it does in PKI interacting with Glu 203.
The fact that RI and RII interact differentially with the C subunit at P-6 to P-4 proximal to the active cleft could also has significant consequences for the overall hydrodynamic features of the type I and type II holoenzymes. If P-6 to P-4 residues direct R subunits in different directions, then the Nterminal dimerization domain which is also the docking site for AKAPs could be oriented differently relative to the rest of the protein for RI and RII. This difference in orientation of the N-termini of R subunits would eventually lead to different overall structures between type I and type II PKA holoenzymes ( Figure 6 ). The Stokes radius of the type I holoenzyme (52 Å) vs. the type II holoenzyme (57 Å) is indicative of significant differences in overall shape and, therefore, supports our interpretation.
cAMP-dependent protein kinase isoforms observations that the type I holoenzyme is sensitive to dissociation with high salt or histones (28) which both would disrupt the acid rich tail and lead to the release of ATP and activation of the holoenzyme. In contrast, the same region in RII could interact with the N-terminal proximal side of the inhibitor recognition site of C in a similar way as PKI, making contact with C(R133A) and the P-11 hydrophobic pocket. These interactions are exclusively with the large lobe and do not require a closed conformation. In addition, they are hydrophobic and thus would not be as sensitive to salt. The presence of a phosphor-Ser at the P site of the RII subunits further dictates that the conformation of C when it is bound to RII will assume a more open conformation. These interactions will orient the N-terminal dimerization domain of RII towards the large lobe ( Figure 6 ). This diversity in peptide recognition in close proximity to the active site also has implications for peptide substrate specificity and may explain the lack of single consensus sequence for substrates of PKA (31) . helix of the C-subunit significantly affected the interaction between the C-subunit and RII subunit, but not the RI subunit (51) . Collectively, these data and our current study strongly support a model that the orientation of the N-terminus of the R-subunit is isoform-specific and that differential interaction between the R subunit isoforms and the C-subunit at the region N-terminal to the pseudo substrate site maybe responsible for this difference.
The effects of the R133A mutation on the C-PKI interaction vs. RI confirm that the region responsible for the high affinity binding of C resides primarily on the N-terminal side of the inhibition site immediate N-terminal to the autoinhibitor sites (underlined) in R subunits are compared to that of PKI . P (the Phosphorylation site), P-3, P-4, P-5, P-6, P-11, and P+1 sites are marked by arrows. shown are the residues that contribute to the P-2 site (Glu230 and Glu170) and P-11 site (Tyr236, Pro236
and Phe239). The P-3 to P+1 portion of consensus site peptide from the MnATP:PKI(5-24):C-subunit ternary complex (1ATP) is also shown. The boxes indicate the two surfaces thought to be complemented by RI and RII, respectively. The figure was generated from the ternary complex where PKI(5-24) was deleted using the GRASP program. 
